ESR1 and metastatic neoplasm: Coradini et al. conducted a single institution retrospective study for women age ≥ 70 with non-metastatic disease to explore the predictive ability of pathologic specimen tumor expression of the biological markers ER, PR, pS2 protein, and cathepsin D (CathD) for post-surgical disease-free survival [16].